In Vitro Diagnostics

PreTect SEE®

PreTect SEE is a real-time nucleic acid amplification-based (NASBA) qualitative assay for specific genotyping of E6/E7 mRNA from HPV 16, HPV 18 and HPV 45, including Intrinsic sample control (ISC).

PreTect SEE is an assay for the qualitative detection of the presence of Human Papillomavirus (HPV) E6/E7 oncogene mRNA from carcinogenic HPV types 16, 18 and 45. ISC (intrinsic sample control) is included in order to assess specimen quality and reveal possible factors that may inhibit the amplification. The kit is based on real-time NASBA technology combining nucleic acid amplification and homogenous detection with Molecular Beacon probes. The test will be used by professionals in order to identify pre-cancer or cancer related to the carcinogenic HPV types included and is a valuable tool for identifying women in risk of having or developing cancer. PreTect SEE is ideal as a quality control test for NILM cytology.


  • Pre-filled microtiter plate or strips with reagents ready for addition of sample.
  •  Positive and negative controls for HPV 16 , HPV 18, HPV 45 and ISC
  •  High sample capacity – up to 94 samples per run
  •  Low hands-on time



Platform/instrument: Fluorescence reader. Please contact PreTect for information on supported readers.

Software: PreTect Analysis Software (PAS)

Sample preservatives:

  • PreTect TM
  • PreservCyt® /ThinPrep®
  • SurePath®


Please note that Isolation Reagents for Nucleic acids are not included in the kit. RNA (or total nucleic acids) from the collected samples have to be isolated prior to analysis. PreTect X and PreTect X Lysis Buffer are validated against this assay.

Related products

PreTect SEE® Order

Welcome to our order request form. Please provide the following details to place your order efficiently.